文献速递功能神经外科

专用直线加速器放射外科治疗经典三叉神经痛:单中心长期随访经验

Dedicated Linear Accelerator Radiosurgery for Classic Trigeminal Neuralgia: A Single-Center Experience with Long-Term Follow-Up.
PubMed 文献 · World Neurosurg · 2018-10-09

单中心2006至2015年采用专用直线加速器放射外科治疗301例经典三叉神经痛患者,处方剂量90 Gy,平均随访54.6个月。90.7%患者初始疼痛完全缓解,5年维持无药物疼痛缓解概率65.8%,10年48.1%,仅26.2%出现感觉减退,作者认为直线加速器可作为药物难治性三叉神经痛的治疗选择。

要点

  • 专用直线加速器放射外科治疗301例,处方剂量90 Gy,平均随访54.6个月。
  • 90.7%患者初始疼痛完全缓解,5年无药物疼痛缓解概率65.8%,10年48.1%。
  • 仅26.2%出现感觉减退,0.3%为非常困扰,无痛性麻木报告。

核心结论

  • 专用直线加速器立体定向放射外科与高比例长期疼痛缓解相关,创伤小且并发症罕见。
  • 作者认为直线加速器是药物难治性三叉神经痛的可能治疗选择,并可与其他手术方案一起向选定患者提议作为首选治疗。

研究设计与样本

  • 单中心研究,2006年至2015年间在本机构接受直线加速器治疗的患者301例。
  • 处方放射剂量为远前靶点90 Gy,临床反应采用Barrow神经病学研究所量表评估,I级和IIIa级视为成功反应。
  • 平均随访时间54.6个月(范围12-132个月)。

主要发现

  • 273例(90.7%)初始疼痛完全缓解,28例(9.3%)无变化。
  • 维持有或无药物疼痛缓解(Barrow神经病学研究所I级和IIIa级)的保险精算概率在0.5、1、2、4、5和10年分别为88.7%、85.0%、76.1%、68.8%、65.8%和48.1%。
  • 感觉减退仅见于26.2%患者(非常困扰者0.3%),无痛性麻木报告。
  • 无进一步手术维持疼痛缓解的保险精算概率在0.5、1、2、4和5年分别为99.3%、98.3%、95.8%、91.0%和89.7%。
  • 在所有治疗患者中,86.5%对手术满意并愿意再次接受立体定向放射外科治疗。

关键数值与推荐

  • 临床反应采用Barrow神经病学研究所量表,I级和IIIa级视为成功反应。
  • 处方放射剂量为远前靶点90 Gy。

临床怎么用

  • 作者认为直线加速器是药物难治性三叉神经痛的可能治疗选择,并可与其他手术方案一起向选定患者提议作为首选治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During the past decades, stereotactic radiosurgery, and Gamma Knife in particular, has proved its safety and efficacy for drug-resistant classic trigeminal neuralgia. However, few large series exist using linear accelerator (LINAC) reporting long-term follow-up. METHODS: Between 2006 and 2015, 301 patients were treated by LINAC at our institution. The prescribed radiation dose was 90 Gy at the far anterior target. Clinical response was defined using the Barrow Neurological Institute scale. We considered grades I and IIIa as a successful response. Mean duration of follow-up was 54.6 months (range, 12-132 months). RESULTS: Two hundred and seventy-three patients (90.7%) were initially pain free, and 28 patients (9.3%) were unchanged. The actuarial probabilities of maintaining pain relief with or without medication (Barrow Neurological Institute grade I and IIIa) at 0.5, 1, 2, 4, 5, and 10 years were 88.7%, 85.0%, 76.1%, 68.8%, 65.8%, and 48.1%, respectively. Hypesthesia was present in only 26.2% of patients (very bothersome, 0.3%). No anesthesia dolorosa was reported. The actuarial probabilities of maintaining pain relief without further surgery at 0.5, 1, 2, 4, and 5 years were 99.3%, 98.3%, 95.8%, 91.0%, and 89.7%, respectively. Among all treated patients, 86.5% were satisfied by the procedure and would undergo stereotactic radiosurgery again. CONCLUSIONS: Stereotactic radiosurgery with dedicated LINAC is associated with high rates of long-term pain relief, with minimal invasiveness and rare complications. LINAC is a possible therapeutic alternative for drug-resistant trigeminal neuralgia and could be proposed to selected patients as the first intention therapy, among other surgical solutions.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Debono B, Lotterie JA, Sol JC, et al. Dedicated Linear Accelerator Radiosurgery for Classic Trigeminal Neuralgia: A Single-Center Experience with Long-Term Follow-Up. World Neurosurg. 2018. PMID: 30312817. doi:10.1016/j.wneu.2018.09.222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。